List of Tables
Table 1. Global ircular RNA Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global ircular RNA Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global ircular RNA Synthesis Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global ircular RNA Synthesis Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global ircular RNA Synthesis Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global ircular RNA Synthesis Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global ircular RNA Synthesis Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ircular RNA Synthesis Service as of 2024)
Table 11. Global ircular RNA Synthesis Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global ircular RNA Synthesis Service Companies Headquarters
Table 13. Global ircular RNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global ircular RNA Synthesis Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global ircular RNA Synthesis Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global ircular RNA Synthesis Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global ircular RNA Synthesis Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. ircular RNA Synthesis Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America ircular RNA Synthesis Service Growth Accelerators and Market Barriers
Table 25. North America ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe ircular RNA Synthesis Service Growth Accelerators and Market Barriers
Table 27. Europe ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific ircular RNA Synthesis Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America ircular RNA Synthesis Service Investment Opportunities and Key Challenges
Table 31. Central and South America ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa ircular RNA Synthesis Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa ircular RNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. GenScript Corporation Information
Table 35. GenScript Description and Major Businesses
Table 36. GenScript Product Features and Attributes
Table 37. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. GenScript Revenue Proportion by Product in 2024
Table 39. GenScript Revenue Proportion by Application in 2024
Table 40. GenScript Revenue Proportion by Geographic Area in 2024
Table 41. GenScript ircular RNA Synthesis Service SWOT Analysis
Table 42. GenScript Recent Developments
Table 43. Guangzhou IGE Biotechnology Corporation Information
Table 44. Guangzhou IGE Biotechnology Description and Major Businesses
Table 45. Guangzhou IGE Biotechnology Product Features and Attributes
Table 46. Guangzhou IGE Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Guangzhou IGE Biotechnology Revenue Proportion by Product in 2024
Table 48. Guangzhou IGE Biotechnology Revenue Proportion by Application in 2024
Table 49. Guangzhou IGE Biotechnology Revenue Proportion by Geographic Area in 2024
Table 50. Guangzhou IGE Biotechnology ircular RNA Synthesis Service SWOT Analysis
Table 51. Guangzhou IGE Biotechnology Recent Developments
Table 52. Geneseed Corporation Information
Table 53. Geneseed Description and Major Businesses
Table 54. Geneseed Product Features and Attributes
Table 55. Geneseed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Geneseed Revenue Proportion by Product in 2024
Table 57. Geneseed Revenue Proportion by Application in 2024
Table 58. Geneseed Revenue Proportion by Geographic Area in 2024
Table 59. Geneseed ircular RNA Synthesis Service SWOT Analysis
Table 60. Geneseed Recent Developments
Table 61. Azenta Life Sciences Corporation Information
Table 62. Azenta Life Sciences Description and Major Businesses
Table 63. Azenta Life Sciences Product Features and Attributes
Table 64. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Azenta Life Sciences Revenue Proportion by Product in 2024
Table 66. Azenta Life Sciences Revenue Proportion by Application in 2024
Table 67. Azenta Life Sciences Revenue Proportion by Geographic Area in 2024
Table 68. Azenta Life Sciences ircular RNA Synthesis Service SWOT Analysis
Table 69. Azenta Life Sciences Recent Developments
Table 70. Beyotime Corporation Information
Table 71. Beyotime Description and Major Businesses
Table 72. Beyotime Product Features and Attributes
Table 73. Beyotime Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Beyotime Revenue Proportion by Product in 2024
Table 75. Beyotime Revenue Proportion by Application in 2024
Table 76. Beyotime Revenue Proportion by Geographic Area in 2024
Table 77. Beyotime ircular RNA Synthesis Service SWOT Analysis
Table 78. Beyotime Recent Developments
Table 79. Packgene Biotech Corporation Information
Table 80. Packgene Biotech Description and Major Businesses
Table 81. Packgene Biotech Product Features and Attributes
Table 82. Packgene Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Packgene Biotech Recent Developments
Table 84. Yaohai Biological Corporation Information
Table 85. Yaohai Biological Description and Major Businesses
Table 86. Yaohai Biological Product Features and Attributes
Table 87. Yaohai Biological Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Yaohai Biological Recent Developments
Table 89. Creative Biogene Corporation Information
Table 90. Creative Biogene Description and Major Businesses
Table 91. Creative Biogene Product Features and Attributes
Table 92. Creative Biogene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Creative Biogene Recent Developments
Table 94. LGC Biosearch Technologies Corporation Information
Table 95. LGC Biosearch Technologies Description and Major Businesses
Table 96. LGC Biosearch Technologies Product Features and Attributes
Table 97. LGC Biosearch Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. LGC Biosearch Technologies Recent Developments
Table 99. CircNova Corporation Information
Table 100. CircNova Description and Major Businesses
Table 101. CircNova Product Features and Attributes
Table 102. CircNova Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CircNova Recent Developments
Table 104. BOC Sciences Corporation Information
Table 105. BOC Sciences Description and Major Businesses
Table 106. BOC Sciences Product Features and Attributes
Table 107. BOC Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. BOC Sciences Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. ircular RNA Synthesis Service Product Picture
Figure 2. Global ircular RNA Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Chemical Synthesis Method Product Picture
Figure 4. Ligase Method Product Picture
Figure 5. Ribozyme Method Product Picture
Figure 6. Global ircular RNA Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Drug Discovery
Figure 8. Cell Therapy
Figure 9. Vaccine R&D
Figure 10. Disease Mechanism
Figure 11. ircular RNA Synthesis Service Report Years Considered
Figure 12. Global ircular RNA Synthesis Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 14. Global ircular RNA Synthesis Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global ircular RNA Synthesis Service Revenue Market Share by Region (2020-2031)
Figure 16. Global ircular RNA Synthesis Service Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Chemical Synthesis Method Revenue Market Share by Player in 2024
Figure 19. Ligase Method Revenue Market Share by Player in 2024
Figure 20. Ribozyme Method Revenue Market Share by Player in 2024
Figure 21. Global ircular RNA Synthesis Service Revenue Market Share by Type (2020-2031)
Figure 22. Global ircular RNA Synthesis Service Revenue Market Share by Application (2020-2031)
Figure 23. North America ircular RNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players ircular RNA Synthesis Service Revenue (US$ Million) in 2024
Figure 25. North America ircular RNA Synthesis Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America ircular RNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 27. US ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 28. Canada ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 30. Europe ircular RNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players ircular RNA Synthesis Service Revenue (US$ Million) in 2024
Figure 32. Europe ircular RNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe ircular RNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 35. France ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 37. Italy ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 38. Russia ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific ircular RNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players ircular RNA Synthesis Service Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific ircular RNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific ircular RNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 44. Japan ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 46. Australia ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 47. India ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore ircular RNA Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America ircular RNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players ircular RNA Synthesis Service Revenue (US$ Million) in 2024
Figure 55. Central and South America ircular RNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America ircular RNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa ircular RNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players ircular RNA Synthesis Service Revenue (US$ Million) in 2024
Figure 61. South America ircular RNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa ircular RNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 64. Israel ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa ircular RNA Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 67. ircular RNA Synthesis Service Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
